EA200501781A1 - PHARMACEUTICAL COMPOSITION CONTAINING ZOFENOPRYL AND HCTZ FOR TREATMENT OF HYPERTENSION - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING ZOFENOPRYL AND HCTZ FOR TREATMENT OF HYPERTENSION

Info

Publication number
EA200501781A1
EA200501781A1 EA200501781A EA200501781A EA200501781A1 EA 200501781 A1 EA200501781 A1 EA 200501781A1 EA 200501781 A EA200501781 A EA 200501781A EA 200501781 A EA200501781 A EA 200501781A EA 200501781 A1 EA200501781 A1 EA 200501781A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hctz
zofenopryl
hypertension
treatment
pharmaceutical composition
Prior art date
Application number
EA200501781A
Other languages
Russian (ru)
Other versions
EA012845B1 (en
Inventor
Пьеро Рийли
Джованни Вити
Original Assignee
Менарини Интернэшнл Оперейшнс Люксембург С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Менарини Интернэшнл Оперейшнс Люксембург С.А. filed Critical Менарини Интернэшнл Оперейшнс Люксембург С.А.
Priority to EA200501781A priority Critical patent/EA012845B1/en
Publication of EA200501781A1 publication Critical patent/EA200501781A1/en
Publication of EA012845B1 publication Critical patent/EA012845B1/en

Links

Abstract

Изобретение относится к пероральным лекарственным формам, содержащим кальциевую соль зофеноприла, в частности к твердым пероральным лекарственным формам, содержащим комбинацию полиморфной модификации А зофеноприла, по существу, без примеси полиморфной модификации В и гидрохлортиазида (HCTZ), и к способам их получения.The invention relates to oral dosage forms containing zofenopril calcium salt, in particular to solid oral dosage forms containing a combination of polymorphic modification A of zofenopril, essentially without admixture of polymorphic modification B and hydrochlorothiazide (HCTZ), and methods for their preparation.

EA200501781A 2005-12-09 2005-12-09 Pharmaceutical compositions comprising zofenopril and hctz for treating hypertension EA012845B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200501781A EA012845B1 (en) 2005-12-09 2005-12-09 Pharmaceutical compositions comprising zofenopril and hctz for treating hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200501781A EA012845B1 (en) 2005-12-09 2005-12-09 Pharmaceutical compositions comprising zofenopril and hctz for treating hypertension

Publications (2)

Publication Number Publication Date
EA200501781A1 true EA200501781A1 (en) 2007-06-29
EA012845B1 EA012845B1 (en) 2009-12-30

Family

ID=41263879

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501781A EA012845B1 (en) 2005-12-09 2005-12-09 Pharmaceutical compositions comprising zofenopril and hctz for treating hypertension

Country Status (1)

Country Link
EA (1) EA012845B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
IT1301993B1 (en) * 1998-08-04 2000-07-20 Menarini Ricerche Spa PROCESS FOR THE PREPARATION OF ZOFENOPRIL CALCIUM SALT.
RU2229298C1 (en) * 2003-02-13 2004-05-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Pharmaceutical composition eliciting cardiovascular effect and method for it preparing

Also Published As

Publication number Publication date
EA012845B1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
EA200601773A1 (en) TETRAAZABENZO [E] AZULENE DERIVATIVES AND THEIR ANALOGUES
EA201100814A1 (en) PHARMACEUTICAL FORMS OF APPLICATION CONTAINING NIFEDIPINE OR NIZOLDIPIN AND ANTAGONIST ANGIOTENZINE II AND / OR DIURETIC
EA201171403A1 (en) SUSTAINABLE ORAL PHARMACEUTICAL DOSED FORMS CONTAINING OPIOID ANALGETIC
EA200900802A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
NO20064325L (en) Heteroberlaminopyrazole derivatives useful for the treatment of diabetes
EA200900613A1 (en) SPIROKETONE ACETYL-COA-CARBOXYLAS INHIBITORS
EA200901133A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
EA200802007A1 (en) COMPOUNDS POTENTIATING AMPA RECEPTOR AND APPLICATION OF THE SPECIFIED COMPOUNDS IN MEDICINE
EA200970581A1 (en) CRISTAL TREATMENT BASIS BACKGROUND
EA200702253A1 (en) PHARMACEUTICAL COMPOSITION
EA200600078A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
EA201001680A1 (en) COMPOUNDS OF BENZOLSULPHONAMIDTIAOSOL AND OXAZOL
EA201200669A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA200700851A1 (en) OBTAINING AND APPLICATION OF BIPHENYL-4-ILKARBONYLAMINO ACID DERIVATIVES FOR TREATMENT OF OBESITY
EA200800760A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA201100691A1 (en) ANTAGONISTS OF LYSOPHPATIDIC ACID RECEPTORS
EA200870569A1 (en) CONNECTIONS AND METHODS OF FXR MODULATION
EA201500430A1 (en) COMPOUNDS OF BONONATE AIR AND ITS PHARMACEUTICAL COMPOSITIONS
EA200901138A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
EA200601239A1 (en) REPLACED QUINOLINE COMPOUNDS
EA201000220A1 (en) IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING ANTAGONIST OF DIHYDROPYRIDIN CALCIAN CHANNEL AND METHOD FOR ITS OBTAINING
EA200801481A1 (en) 5- (AROSULFONYL) PYRAZOLOPIPERIDES
TR201907381T4 (en) Beta-lactamyl phenylalanine, cysteine and serine vasopressin antagonist.
DK1654253T3 (en) Substituted 3-pyrrolidine indole derivatives
EA200900900A1 (en) DERIVATIVES OF SUBSTITUTED 3-PHENYL-1- (PHYNYLENEENYL) PROPAN-1-ONES AND 3-PHENYL-1- (PHENYL-FURANIL) PROPAN-1-ONES, THEIR RECEIVING AND APPLICATION

Legal Events

Date Code Title Description
ND4A Extension of term of a eurasian patent